KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Accounts Payables: 2010-2015

Historic Accounts Payables for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to $3.8 million.

  • Biocryst Pharmaceuticals' Accounts Payables rose 66.90% to $3.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $3.8 million, marking a year-over-year increase of 66.90%. This contributed to the annual value of $2.8 million for FY2014, which is 31.74% down from last year.
  • Biocryst Pharmaceuticals' Accounts Payables amounted to $3.8 million in Q3 2015, which was down 1.05% from $3.8 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' Accounts Payables' 5-year high stood at $5.3 million during Q1 2015, with a 5-year trough of $1.2 million in Q3 2013.
  • Its 3-year average for Accounts Payables is $3.0 million, with a median of $2.8 million in 2014.
  • Its Accounts Payables has fluctuated over the past 5 years, first crashed by 69.55% in 2011, then surged by 292.53% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Accounts Payables (Quarterly) stood at $2.5 million in 2011, then skyrocketed by 59.15% to $4.0 million in 2012, then increased by 5.03% to $4.2 million in 2013, then plummeted by 31.74% to $2.8 million in 2014, then spiked by 66.90% to $3.8 million in 2015.
  • Its Accounts Payables was $3.8 million in Q3 2015, compared to $3.8 million in Q2 2015 and $5.3 million in Q1 2015.